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Abstract
Genome-wide association studies have revealed an association between variation at the SLC4A7 locus and blood pressure.
SLC4A7 encodes the electroneutral Naþ/HCO3 co-transporter NBCn1 which regulates intracellular pH (pHi). We conducted a
functional study of variants at this locus in primary cultures of vascular smooth muscle and endothelial cells. In both cell
types, we found genotype-dependent differences for rs13082711 in DNA-nuclear protein interactions, where the risk allele is
associated with increased SLC4A7 expression level, NBCn1 availability and function as reflected in elevated steady-state pHi
and accelerated recovery from intracellular acidosis. However, in the presence of Naþ/Hþexchange activity, the SLC4A7 geno-
typic effect on net base uptake and steady-state pHi persisted only in vascular smooth muscle cells but not endothelial cells.
We found no discernable effect of the missense polymorphism resulting in the amino acid substitution Glu326Lys. The find-
ing of a genotypic influence on SLC4A7 expression and pHi regulation in vascular smooth muscle cells provides an insight
into the molecular mechanism underlying the association of variation at the SLC4A7 locus with blood pressure.
Introduction
Hypertension is a common and a major etiological factor in
cardiovascular, cerebrovascular and renovascular disease,
estimated to cause up to 12.8% of global mortality and 3.7% of
morbidity (1), with its complications contributing to a major
worldwide economic burden (2). To compound the population
health issue, up to 30% of patients with hypertension are
†These authors share the senior authorship.
Received: October 29, 2016. Revised: December 21, 2016. Accepted: December 30, 2016
VC The Author 2017. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
989
Human Molecular Genetics, 2017, Vol. 26, No. 5 989–1002
doi: 10.1093/hmg/ddx015
Advance Access Publication Date: 13 January 2017
Original Article
Downloaded from https://academic.oup.com/hmg/article-abstract/26/5/989/2901820
by Kobenhavns Universitets user
on 22 May 2018
inadequately treated (3), indicating a need for novel therapeutic
approaches. There is a strong contribution from genes and their
interaction with the environment to blood pressure (BP) regula-
tion and the pathogenesis of hypertension (4,5). Recently,
genome-wide association studies (GWAS) have identified a num-
ber of genomic loci at which common genetic variants have influ-
ences on BP (6–14). The study presented here attempts to
translate the genetic information on a gene relevant to hyperten-
sion into a biomedical context. The identification of a path linking
genetic variation to protein availability, protein activity and sub-
sequently cellular behaviours provides further confidence in pur-
suing NBCn1 as a potential therapeutic target in hypertension.
One of the BP-associated loci identified by GWAS is on chromo-
some 3p24.1 encompassing the SLC4A7 (solute carrier family 4
member 7, HGNC: 11033) gene (8). The lead GWAS single nucleotide
polymorphism (SNP), rs13082711 (NC_000003.12:g.27496418T>C),
at this locus showed an association with diastolic BP above the
genome-wide significance threshold and a similar direction for sys-
tolic BP (P¼ 3.8 109 and 1.5 106, respectively) in a large-scale
GWAS by the International Consortium for Blood Pressure (8). This
SNP is in strong linkage disequilibrium with 92 other SNPs (LD,
r2>0.8; Supplementary Material, Fig. S1A), with only one being a
non-synonymous polymorphism (rs3755652; NC_000003.12:g.
27431445C>T; Glu326Lys).
The SLC4A7 gene encodes NBCn1, an electroneutral Naþ/HCO3
co-transporter (15). At typical intracellular and extracellular ion
concentrations, NBCn1 mediates electroneutral symport of
Naþand HCO3 into cells. Amongst cells expressing NBCn1 are
those that play important roles in BP control, including vascular
smooth muscle cells (VSMCs) (16–18), endothelial cells (VECs)
(16,17,19) and epithelial cells of the medullary thick ascending limb
of the loop of Henle (17,20,21). NBCn1 is known to have a role in
controlling pHi in VSMCs and VECs (18,19); and pHi is a determinant
of VSMC contractility (19,22–24) and endothelial function (19,23–26),
both of which impact BP. In support, it has been shown that pHi
dysregulation in SLC4A7 knockout mice results in an altered BP
phenotype where the knockout mice show resistance to hyperten-
sive stimuli such as angiotensin II, as compared to wildtypes (19).
In this study, we investigated if the BP-associated genetic
variants at the SLC4A7 locus identified by GWAS affect SLC4A7
expression, NBCn1 protein availability and pHi regulation in
VSMCs and VECs. This is important for understanding the func-
tional effects of these genetic variants and the mechanisms as-
sociated with their influence on BP.
Results
Allelic difference in SLC4A7 expression level
The lead BP GWAS SNP rs13082711 is in high LD (r20.8) with 92
other SNPs which together span a 134 kb genomic interval.
SLC4A7 is the only gene located within this interval
(Supplementary Material, Fig. S1A) and the genes closest on ei-
ther side are NEK10 (NIMA-related kinase 10, HGNC: 18592) and
EOMES (eomesodermin, HGNC: 3372) residing 255 and 232 kiloba-
ses, respectively, away from the lead BP SNP. To investigate if the
BP-associated variants influence the expression of SLC4A7, NEK10
and/or EOMES, we first performed RT-PCR assays of these
genes to determine if they were expressed in VSMCs and/or
VECs. These assays showed that SLC4A7 was consistently ex-
pressed in both cell types, whereas neither NEK10 nor EOMES was
expressed in either cell type (Supplementary Material, Fig. S1B).
Having found that SLC4A7 was expressed, but both NEK10 and
EOMES were not readily detected in VSMCs and VECs, we
conducted subsequent experiments focusing on SLC4A7, starting
with allelic expression imbalance analyses. Since this technique
entailed the analysis of a SNP in the coding region, we analyzed
the non-synonymous coding SNP rs13096477 (NC_000003.12:g.
27448703T>C) which is in strong LD (r2>0.95) with the BP GWAS
index SNP rs13082711 located upstream of the gene and therefore
not directly analyzed in this assay. The analyses showed that in
both VSMCs and VECs, SLC4A7 RNA expression level of the BP-
raising (minor, C) allele at rs13096477 was higher as compared to
that of the alternative (major, T) allele (Fig. 1A and B).
To investigate the potential molecular mechanism leading to
the allelic difference in SLC4A7 RNA level described above, we as-
certained whether there was an allelic effect on DNA-nuclear pro-
tein interaction, an important aspect in gene transcriptional
regulation. To this end, we undertook formaldehyde-associated
isolation of regulatory elements (FAIRE) studies coupled with alle-
lic imbalance assay to investigate if there was an allelic-
dependent difference in nuclear protein binding in the intact cel-
lular environment. Since this technique required analysis of an
intragenic SNP, as for the allelic expression imbalance assay de-
scribed above, we again analyzed the SNP rs13096477. The analy-
sis showed an allelic imbalance of rs13096477, with its minor (BP-
elevating, T) allele being in preferentially open chromatin confor-
mation in VSMCs (Supplementary Material, Fig. S2A). This allelic
imbalance in DNA-protein binding was not detected in VECs.
Since rs13096477 and rs13082711 are in high LD (r20.8) with 92
other SNPs, and the FAIRE allelic imbalance assay technique
could not provide information about which of these SNPs in high
LD was responsible for the allelic imbalance results described above,
we carried out electrophoretic mobility shift assays (EMSA) on 10 se-
lected SNPs among the 93 in high LD, prioritized based on their posi-
tions relative to the start of SLC4A7 transcription and transcription
factor binding site predictions from various bioinformatics re-
sources including ENCODE and RegulomeDB (Supplementary
Material, Fig. S2B). EMSAs on the 10 tested SNPs showed VSMC nu-
clear protein binding preferentially to the major allele of rs13096477
but, the minor allele of rs2371065 (NC_000003.12:g.27453098A>C),
and weakly to the minor allele of rs13077400 (NC_000003.12:g.
27431575A>G) (Fig. 2A, Supplementary Material, Fig. S3A–C). In con-
trast, neither allele of the BP GWAS index SNP rs13082711 showed
DNA-protein interaction in EMSAs. Consistent with the FAIRE re-
sults mentioned above, EMSAs with VEC nuclear protein extracts
did not detect binding with any of the DNA probes for the 10 tested
SNPs (Fig. 2B).
Since the above EMSAs showed allele-specific binding of a
nuclear protein to the rs2371065 minor allele, we undertook fur-
ther experiments in an attempt to determine the identity of this
nuclear protein. We performed supershift assays with antibod-
ies against the nuclear proteins PHOX2A, PLAG1 and TFAP2C,
respectively, as bioinformatics analyses showed that their rec-
ognition DNA sequences had some similarities with the DNA
sequence encompassing the rs2371065 site. However, these as-
says show no evidence to suggest that any of these proteins be-
ing the one interacting with the rs2371065 minor allele shown
in EMSAs (Supplementary Material, Fig. S4). We next conducted
a DNA pull-down assay using a biotin-labelled double-stranded
oligonucleotide corresponding to the DNA sequence at and sur-
rounding the site of the rs2371065 minor allele. An electropho-
retic analysis of proteins pulled down by this oligonucleotide
showed two bands consistent with the EMSA results described
earlier, neither of which was present in the negative control
(Supplementary Material, Fig. S5). However, N-terminal protein
sequencing failed to reveal the identity of the protein(s) pulled
down by the oligonucleotide.
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Allelic difference in NBCn1 protein level
Having found an allelic difference in SLC4A7 RNA expression level
as described above, we investigated if there was a corresponding
difference in NBCn1 protein level. Immunoblot analyses of VSMC
total cellular protein extracts showed that NBCn1 protein levels
were the greatest in minor (BP-raising) allele homozygotes, inter-
mediate in heterozygotes and lowest in major allele homozygotes
(Fig. 3A and B). Despite the allelic imbalance in RNA/cDNA levels,
there were no detected genotypic differences in VEC total cellular
NBCn1 protein expression (Fig. 4A and B).
Following the above analysis of total cellular NBCn1, we ex-
amined NBCn1 in subcellular locations, more specifically, their
presence at the cellular membrane. An immunoblot analysis of
subcellular protein fractionations prepared by differential centri-
fugation showed that the cells carrying the BP-raising allele (C/T
genotype for rs13082711) had higher levels of NBCn1 in the mem-
brane fraction as compared to non-carriers (T/T genotype) in both
VSMCs (Fig. 3C) and VECs (Fig. 4C). The vesicle and organelle frac-
tion also contained NBCn1 but the difference between the geno-
types was less pronounced. The supernatant (cytosolic) fraction
had no detectable expression of NBCn1 or the plasma membrane
markers N-cadherin and VE-cadherin.
Association of the BP-raising allele with increased
Naþ/HCO3 co-transport activity in VSMCs, which is
not overcome by Naþ/Hþexchange activity
To determine whether the increased SLC4A7 gene expression and
NBCn1 protein availability at the plasma membrane in cells car-
rying the BP-raising allele gives rise to increased protein function,
the capacity of these primary cultured cells for pHi recovery from
NHþ4 -prepulse-induced intracellular acidification was assessed.
Comparing VSMCs from BP-raising allele carriers (C/T risk allele
carriers at rs13082711, n¼ 5) and protective allele homozygotes
(T/T genotype, n¼ 7), we observed a difference in pHi recovery
rate following intracellular acidosis in cells exposed to the Naþ/
Hþexchange inhibitor dimethylamiloride (DMA, 30 mM) in the
presence of CO2/HCO

3 (Fig. 5A). As the activities of acid-base
transporters are regulated by pHi, the rate of net base uptake was
determined at regular pHi intervals (Fig. 5B), demonstrating a ge-
notype effect, where VSMCs from the rs13082711 BP-raising allele
carriers had a higher rate of net base uptake at each pHi com-
pared to protective allele homozygotes. In addition to differences
in net base uptake rates, there was also a genotype effect on final
plateau pHi that was revealed in the presence of DMA
(DpHi¼0.08760.027, P< 0.01) (Fig. 5C). This observed genetic in-
fluence was confirmed to be CO2/HCO

3 -dependent as the differ-
ence in net base uptake and final resting pHidisappears in CO2/
HCO3 -free conditions (Supplementary Material, Fig. S6A–C).
To minimize the potential effects of variances in cell cycles,
the VSMCs were also tested after 48 h of serum-starvation (27).
In this synchronized state, the Naþ- and CO2/HCO

3 -dependent,
DMA-insensitive pHi recovery and the final plateau pHi were
lower than under serum-stimulated conditions but still higher
in BP-raising allele carriers compared to cells homozygous for
the protective allele (Fig. 5D–F).
While these data show a genetic influence on Naþ/HCO3
co-transport activity in the absence of Naþ/Hþexchange
activity (inhibited by DMA), it does not necessarily indicate
an overall effect on pHi under physiological conditions
where Naþ/Hþexchange may play a large role. It is therefore
important to note that in the presence of Naþ/Hþexchange
activity (i.e. in the absence of DMA), the genotype-associated
difference in net base uptake and final plateau pHi persisted
(Fig. 5G–I).
As expected, the buffering capacity of the VSMCs was higher
in the presence of CO2/HCO

3 than in its nominal absence. This
was particularly evident at the pHi ranges closer to physiological
levels where [HCO3 ]i is high and adds substantially to the buff-
ering power (Supplementary Material, Fig. S7A). There were no
differences in buffering capacity between cells of the two as-
sessed genotypes (Supplementary Material, Fig. S7B) in the pres-
ence or absence of CO2/HCO

3 .
Figure 1. The BP risk (minor) allele at the SLC4A7 locus is associated with increased gene expression. (A) Allelic imbalance analyses using heterozygotes at an exonic
SNP (rs13096477), which is in high LD with the GWAS lead SNP (rs13082711). Representative chromatographs of genomic DNA (gDNA) and complementary DNA (cDNA)
for the same sample, with the C/T SNP rs13096477 highlighted in blue, which is quantified in (B), where the C (BP-risk) allele is preferentially observed in cDNA of VSMC
and VEC samples. *P<0.05, **P<0.01, by paired t-test.
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Association of the BP-raising allele with increased
NBCn1 activity in VECs, which is overcome by
Naþ/Hþexchange activity
In a study of VEC samples from BP-raising allele carriers (C/T ge-
notype at rs13082711, n¼ 10) and protective allele homozygotes
(T/T genotype, n¼ 10), no significant difference in pHi recovery
following intracellular acidosis was detected by repeated mea-
sures two-way ANOVA (Fig. 6A) despite the apparent divergence
of the curves in cells exposed to Naþ/Hþexchange inhibition
(30 mM DMA) in the presence of CO2/HCO

3 . When calculated and
plotted as a function of pHi, this revealed a genotype effect on
the rate of net base uptake (Fig. 6B). Similar to VSMCs, there was
a higher final plateau pHi that was revealed in the presence of
DMA for C/T risk allele carriers compared to T/T protective allele
homozygotes (DpHi¼0.08260.053, P¼ 0.10, Fig. 6C). This is a
similar magnitude to that of VSMCs, but due to the larger confi-
dence interval, did not reach statistical significance. Similarly,
there was no significant difference in buffering capacities be-
tween the genotypes of VECs when compared in the pHi range
covered by both the C/T and T/T groups (Supplementary
Material, Fig. S7C and D). Once again, the observed genetic influ-
ence on net base uptake was confirmed to be CO2/HCO

3 -depen-
dent with its disappearance in CO2/HCO

3 -free conditions
(Supplementary Material, Fig. S6D–F).
Similar to the analysis of VSMCs above, a more physiological
condition with uninhibited Naþ/Hþexchange needed to be
considered. In this setting, unlike that of VSMCs, the genotype-
associated difference in VEC net base uptake rate and final
plateau pHi was overcome by the presence of Na
þ/Hþexchange
activity (Fig. 6D–F). Taken in combination, this may indicate
that the BP-associated locus is more likely to exert its effects via
VSMCs rather than VECs.
Bioinformatic tools predict the NBCn1 Glu326Lys
variation to be well tolerated
Having identified that the BP-raising allele (C for rs13082711) is as-
sociated with higher Naþ/HCO3 co-transport activity and steady-
state resting pHi, we wondered whether the missense Glu326Lys
amino acid change (SNP at rs3755652) in high LD with rs13082711
Figure 2. The SLC4A7 BP-associated locus shows allele-dependent DNA-nuclear protein interactions. (A) EMSA with labelled-probes corresponding to both alleles of the
10 highest priority SNPs at SLC4A7. The start codon NEK10 appears on the right or of the figure. Unbound probes as visualized at bottom of autoradiograph.
Representative figure of n¼3 replicates. (B) EMSA comparing VEC and VSMC nuclear extracts for three SNPs shows the shift present in VSMC nuclear extracts virtually
absent with VEC nuclear extracts. Representative figure of n¼2 replicates. All lanes had 10 femtomoles of labelled double-stranded oligonucleotide probe with 10 ng of
corresponding nuclear extracts.
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(r2>0.9) contributes to this effect. The main difference between
glutamic acid and lysine amino acid residues is that the former has
a negative charge; whist the latter has a positive charge. They are
otherwise relatively similar - having similar molecular weights,
both being hydrophilic, and neither is bulky enough to result in ste-
ric hindrance or changes in secondary structures. This similarity is
reflected by the early analysis by Grantham (28), noting that the
functional effect of this amino acid change is predicted to be rela-
tively small. Utilizing seven other online prediction tools, the over-
all consensus was that the Glu326Lys is a well-tolerated amino
acid change (Supplementary Material, Table S1).
The NBCn1 Glu326Lys variant does not affect
NBCn1 activity
To assess the hypothesis that the Glu326Lys variant does not af-
fect NBCn1 activity, we overexpressed the 326Glu and 326Lys var-
iants and a shorter variant that lacks splice Cassette II (amino
acids 251–374, thus lacking the Glu326Lys variation) of NBCn1 in
A10 cells, and assessed their capacity for pHi recovery following
NHþ4 -prepulse-induced intracellular acidosis in the presence of
CO2/HCO

3 and DMA. Cells transfected with any of the three over-
expression plasmids displayed faster pHi recovery from intracel-
lular acidification compared to cells transfected with the control
vector, but there were no differences between the impact of the
three overexpression plasmids (Fig. 7A and B). This was verified
in the analysis accounting for net base uptake rate as a function
of pHi (Fig. 7C). In addition to the increased pHi recovery rate, A10
cells transfected with overexpression plasmids also have a higher
plateau pHi as compared to cells transfected with the control vec-
tor, but again, there were no differences between cells transfected
with the three overexpression plasmids (Fig. 7D). These findings
were obtained with consistent and comparable overall overex-
pression across the three different NBCn1 variants (Fig. 7E and F),
and similar to primary VSMCs and VECs observed before, there
was no difference in buffering capacities (Supplementary
Material, Fig. S7E). These findings suggest that the Glu326Lys
amino acid variation does not alter the intrinsic acid-base trans-
port activity of NBCn1, consistent with the aforementioned bioin-
formatics predictions.
Calcineurin inhibition did not influence Naþ/HCO3
co-transport activity under the experimental conditions
Although there is evidence that NBCn1 activity is regulated by
phosphorylation, perhaps via calcineurin (29,30), the absence of
an effect of either the Glu326Lys amino acid variation, and
the variant that lacks Cassette II (Fig. 7), led us to postulate that
Figure 3. The BP risk (minor) allele at the SLC4A7 locus is associated with increased NBCn1 protein expression and availability at the plasma membrane in VSMCs.
(A) Protein immunoblots for NBCn1 with VSMC samples stratified by genotype at rs13082711, where the two signals for NBCn1 reflecting the isoforms with and without
Cassette II (band sizes approximately 150 kDa and 135 kDa, respectively), quantified in (B), where comparisons across the three genotypes show increased protein ex-
pression for risk allele carriers. *P<0.05, by one-way ANOVA after Bonferroni correction for multiple comparisons. (C) Subcellular fractionation samples from VSMCs,
showing that the BP risk (minor) allele at the SLC4A7 locus is associated with increased NBCn1 signal in the membrane fraction. 2 lg protein of each cellular fraction
was loaded in each lane. n¼9 in each group *P<0.05 by Mann-Whitney U-test.
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the genotypic effect was independent of calcineurin activity.
Furthermore, the genotypic effect was observed in condi-
tions with lower intracellular [Ca2þ], where calcineurin is less
likely to play a role (30). To assess this hypothesis,
primary VSMCs were assessed for Naþ- and CO2/HCO

3 -depen-
dent, DMA-insensitive pHi recovery rate following NH
þ
4 -prepulse-
induced intracellular acidosis while being exposed to 10 mM of the
calcineurin inhibitor FK506 (or equivolume DMSO vehicle). In
these conditions, we did not observe an effect of 10 mM FK506 on
DMA-insensitive Naþ/HCO3 co-transport activity (Supplementary
Fig. S8A and B) and it stands to follow that even in the presence
of 10 mM FK506, the genotype-associated difference in DMA-
insensitive Naþ/HCO3 co-transport activity persists
(Supplementary Material, Fig. S8C and D).
To confirm the above findings from primary VSMCs,
A10 cells transfected with the three different overexpression
plasmids (326Lys, 326Glu and the variant without splice
cassette II) were also investigated under the same conditions.
Consistent with the findings from primary VSMCs, A10 cells
transfected with the different overexpression plasmids con-
tinues to show the lack of effect of calcineurin inhibition by 10
mM FK506 on Naþ/HCO3 co-transport activity (Supplementary
Material, Fig. S8E and F). Again these findings are consistent
with previous reports that calcineurin inhibition only
affects NBCn1 activity under conditions of elevated intracellular
[Ca2þ] (30).
Discussion
We here identify a potential mechanism for the impact of the
SLC4A7 BP-associated locus on vascular cells. Mechanistically,
our studies demonstrate allele-associated differences in DNA-
nuclear protein interaction, gene expression and NBCn1
function, where the carriers of the SLC4A7 BP risk allele demon-
strated increased NBCn1 protein expression, and in turn, upre-
gulated net base uptake rate and higher steady-state pHi.
Although the increased expression and NBCn1 activity are also
found in VECs, the effect on net acid extrusion rate and steady
state pHi was masked by a larger Na
þ/Hþexchange (DMA-sensi-
tive) activity under our experimental conditions.
GWAS have identified multiple genetic loci associated with
BP, each with a modest contribution to overall BP levels. One of
these was found to encompass SLC4A7/NBCn1. NBCn1 regulates
pHi by electroneutral symport of Na
þand HCO3 into cells.
Reduction of NBCn1 activity in VSMCs and VECs, by knockdown
(18) or knockout (19), abolishes Naþ/HCO3 co-transport and
markedly attenuates pHi recovery from intracellular acidosis.
As there appears to be opposing effects of altered NBCn1-
function in VSMCs and VECs on BP demonstrated by the SLC4A7
knockout mouse (19), it is important to identify in which cell
type, if any, NBCn1 allele variation has an effect.
The role of vascular pHi regulation in human hypertension is
supported by the finding that vascular segments from hyperten-
sive patients are more resistant to noradrenaline-induced intra-
cellular acidification than segments from normotensive
controls (31). That study was conducted prior to in-depth char-
acterization of Naþ/HCO3 co-transporters, and more recent re-
ports show that NBCn1-mediated Naþ/HCO3 co-transport has
subsequently been shown to protect VSMCs against intracellu-
lar acidification during contractions (18,30,32). As intracellular
acidification of VSMCs lowers rho-kinase-dependent VSMC
Ca2þsensitivity (19,23), the improved ability to eliminate the
contraction-induced intracellular acid load may contribute to
the higher peripheral arterial resistance of hypertensive pa-
tients through increased rho-kinase activity. Consistent with
the effect of sustained intracellular acidification on VSMC
Figure 4. The BP risk (minor) allele at the SLC4A7 locus is associated with increased NBCn1 availability at the plasma membrane in VECs. (A) shows the protein immu-
noblots for NBCn1 with VEC samples stratified by genotype at rs13082711, and quantified in (B) P>0.05 by Mann-Whitney U-test. (C) Subcellular fractionation samples
from VECs, showing that the BP risk (minor) allele at the SLC4A7 locus is associated with increased NBCn1 signal in the membrane fraction. 2 lg protein of each cellular
fraction was loaded in each lane. n¼8 each group. *P<0.05 by Mann-Whitney U-test.
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Ca2þsensitivity, knockout of NBCn1 lowers noradrenaline-
induced contractions of mesenteric arteries (19) and myogenic
responses of pressurized middle cerebral arteries (24) after
endothelial blockade without affecting VSMC membrane
potential or [Ca2þ]i. There is also evidence that changes in
acid-base transport function and/or pHi impact in vitro VSMC
proliferation (33), migration and viability (34), and medial wall
thickness (23). NBCn1 plays a key role for VSMC migration and
carotid artery remodeling most likely because it establishes lo-
cal pHi gradients and promotes filopodia, which can explain the
decelerated directional migration of VSMCs from NBCn1 knock-
out mice (35). Altered NBCn1 activity could therefore modify
vascular remodeling with long-term impact on peripheral
resistance.
Endothelial function is impaired by intracellular acidosis
(23,25); and endothelial NO production is reduced in SLC4A7
knockout mice without any change in endothelial [Ca2þ]i or NO
synthase expression (19). Intracellular pH has also been
shown to influence the generation of endothelial vasoactive
substances such as the expression of endothelin (26) and the
intrinsic activity of nitric oxide synthase (25). However, the
disappearance of the genotypic effect in VECs when
Naþ/Hþexchange is present suggests that the GWAS identified
genetic variance is unlikely to exert its effect through endothe-
lial function. This is with the caveat of these studies being con-
ducted in an in vitro system, whereas in vivo, endothelial cells
would be exposed to shear stress as well as circulating hor-
monal factors.
Figure 5. The BP risk (minor) allele at the SLC4A7 locus is associated with increased Naþ/HCO3 co-transport activity in VSMCs and is not overcome by Na
þ/Hþexchange
activity. Intracellular pH recovery of VSMCs following NHþ4 -prepulse-induced intracellular acidosis. Experiments were performed with (A–C) CO2/HCO

3 and 30 mM
DMA, (D–F) CO2/HCO

3 and 30 mM DMA, in cell cultures serum-starved for 48 h beforehand, and (G–I) in CO2/HCO

3 conditions. The risk allele carriers (orange, C/T at
rs13082711, n¼5) had faster pHi recovery and higher final plateau pHi compared to protective allele homozygotes (green, T/T at rs13082711, n¼7), even in the absence of
DMA. (A,D,G) Intracellular pH traces of VSMCs during ammonium prepulse studies. Grey error bars denotes SEM. Periods of exposure to 20 mM NH4Cl, Na
þ-free buffers,
or 30 mM DMA are marked above the traces. X-axis scale bar denotes 5 min. Groups compared by repeated-measures two-way ANOVA over the 280 time points between
60 s and 900 s after reintroduction of Naþ-containing buffer. (B,E,H) Net base uptake for each group calculated at specified pHi values. Slopes compared by least-squares
linear regression analyses. (C,F,I) Final plateau pHi after recovery from intracellular acidosis. *P<0.05, **P<0.01 by Mann–Whitney U-test.
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We found that VECs have a higher level of SLC4A7 expres-
sion and faster Naþ- and CO2/HCO

3 -dependent, DMA-
insensitive recovery from intracellular acidosis as compared to
VSMCs (Supplementary Material, Fig. S9). Importantly, the
genotype-associated differences found in Naþ/HCO3 co-
transport activity are masked by Naþ/Hþexchange in VECs, but
not VSMCs. This may be related to the relative contributions of
Naþ/Hþexchange and Naþ/HCO3 co-transport being similar to
each other in VSMCs, especially in the pHi ranges from around
6.7 upwards (Fig. 8A). This would enable subtle genotype-
associated differences in NBCn1 activity to persist in VSMCs,
but not in VECs where Naþ/Hþexchange contribution far out-
weighs that of Naþ/HCO3 co-transport (Fig. 8B). These results
should be taken in relation to the expression of other pHi regu-
lators (Fig. 8C), where a panel of paired VSMC and VEC samples
shows inter-sample variability with SLC4A7 short and long iso-
forms (confirming the previous qRT-PCR and immunoblot re-
sults), but also SLC4A4 (NBCe1) and SLC9A1 (NHE1). Although
mRNA expression of multiple SLC4-family Naþ/HCO3 co-
transporters has also been identified in mouse carotid arteries,
NBCn1 has been found to functionally dominate net acid extru-
sion (35). Notably, we found a minimal signal for SLC4A4 in
VECs.
The genotype-associated changes in overall VSMC pHi regu-
lation may be related not just to resting pHi, but also to the rate
from which pHi recovers from intracellular acidosis; particularly
as pHi is not constant and pHi recovery rates are important in
response to a variety of in vivo vasoconstrictive stimuli such as
angiotensin II, noradrenaline, endothelin-1 and cellular depo-
larization (31,36–38). It is hitherto unknown whether it is the
resting steady-state pHi, or the ability to return towards its set-
point and avoid intracellular acidification during contractions
that predominantly influences the overall in vivo phenotype but
our results show that both the rate of recovery and the resting
levels of pHi are influenced by SLC4A7 genotype.
The direction of effect for the data presented here is congru-
ent with that of the SLC4A7 knockout model (19); where the
knockout mice are protected from the hypertensive stressor an-
giotensin II, we show that the BP-protective allele is associated
with the reduced NBCn1 expression and slower recovery from
intracellular acidosis, particularly in VSMCs. The clinical rele-
vance of the described genotypic effects is supported by obser-
vational data from arterial segments from humans with
hypertension: in human resistance arteries from hypertensive
subjects, the VSMCs were protected from intracellular acidosis
after noradrenaline contraction relative to those from normo-
tensive subjects (31). Additionally, when intracellular acidosis
was induced in mouse mesenteric artery studies, a fall of VSMC
pHi by approximately 0.1 was associated with a decreased
ex vivo contractility (19). The differences in resting pHi (95% CI,
0.08–0.12) and pHi recovery rates (95% CI, 15–55%) that we de-
scribe between the SLC4A7 genotypes – with both parameters
Figure 6. The BP risk (minor) allele at the SLC4A7 locus is associated with increased Naþ/HCO3 co-transport activity in endothelial cells but it is masked by Na
þ/
Hþexchange activity. Intracellular pH recovery of VECs following NHþ4 -prepulse-induced intracellular acidosis. Experiments were performed with (A–C) CO2/HCO

3 and
30 mM DMA and, (D–F) in CO2/HCO

3 conditions. The risk allele carriers (orange, C/T at rs13082711, n¼10) had faster pHi recovery and higher final plateau pHi compared
to protective allele homozygotes (green, T/T at rs13082711, n¼10), but this difference was abolished in the absence of DMA. (A and D) Intracellular pH traces of VECs
during ammonium prepulse studies. Grey error bars denotes SEM. Periods of exposure to 20 mM NH4Cl, Na
þ-free buffers or 30 mM DMA are marked above the traces.
X-axis scale bar denotes 5 min. Groups compared by repeated-measures two-way ANOVA over the 280 time points between 60 s and 900 s after reintroduction of Naþ-
containing buffer. (B and E) Net base uptake for each group calculated at specified pHi values. Slopes compared by least-squares linear regression analyses. (C and F)
Final plateau pHi after recovery from intracellular acidosis.
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higher in rs13082711 risk allele carriers as compared to the pro-
tective allele homozygotes – may be clinically significant if they
continue to persist in vivo.
A recently reported study shows that SNP rs820430, which is
located in an intergenic region 23 kb from SLC4A7 and associ-
ated with BP in a Chinese Han population GWAS (39), has an ef-
fect on SLC4A7 transcription in peripheral blood mononuclear
cells (40). In the present study, we investigated a separate ge-
netic signal represented by rs13082711, the lead BP-associated
SNP in GWASs in Europeans (8), which is not in high LD with
rs820430 (r2¼0.178 in CEU). Our study shows that rs13082711
also affects SLC4A7 expression and reveals that it leads to al-
tered NBCn1 protein levels in VSMCs and VECs which are cell
types that play important roles in controlling BP. Importantly,
our study reveals, for the first time, that the BP-associated ge-
netic variant impacts on pHi regulation, which has a direct and
important implication in BP control.
It should be acknowledged that apart from VECs and VSMCs,
there are other tissues such as the medullary thick ascending
limb of the loop of Henle where SLC4A7 may exert an effect on
BP regulation. Additionally, data from the Genotype-Tissue
Expression (GTEx) Project indicates that SLC4A7 is also ex-
pressed in other tissues such as mammary tissue, transformed
fibroblasts, prostate, lymphocytes, nerves and subcutaneous
adipose tissue. Furthermore, the same database shows an asso-
ciation between the SNP rs13082711 and the expression level of
the neighbouring gene, NEK10, in left ventricles. Possible effects
on these other tissues were not explored in this study, but re-
main a potential parallel mechanism of action for the BP-
associated SNP.
In summary, the work presented here has revealed that the
BP-raising allele of rs13082711 is associated with allele-
dependent DNA-nuclear protein interactions, greater SLC4A7
transcript levels, higher NBCn1 protein levels and plasma mem-
brane availability particularly in VSMCs, and increased rates of
base uptake via Naþ/HCO3 co-transport and higher resting pHi,
once again more apparent in VSMCs. Notably, due to the large
contribution of Naþ/Hþexchange to VEC pHi regulation, the sub-
tle genotypic effect is masked when Naþ/Hþexchange is pre-
sent. This is not the case for VSMCs, where the genotypic effect
persists even in the presence of active Naþ/Hþexchange. The
missense variant Glu326Lys which is in high LD with
rs13082711, had no significant effect on NBCn1 function, sug-
gesting that the functional effect of the BP-associated variant is
predominantly related to an influence on SLC4A7 expression
levels. The identification of a pathophysiological path from BP-
Figure 7. The Glu326Lys amino acid variation at the BP risk locus does not influence NBCn1 activity. Intracellular pH recovery of A10 cells transfected with SLC4A7-ex-
pression plasmids (pcDNA) following NHþ4 -prepulse-induced intracellular acidosis. Experiments were performed with CO2/HCO

3 and 30 mM DMA. Blue denotes Vector;
Brown, 326K (lysine); Black, 326E (glutamic acid); Yellow, without Cassette II. Transfection with any of the three expression plasmids increased pHi recovery and final
plateau pHi compared to vector control (n¼6 sets). (A) Intracellular pH traces of A10 cells transfected with SLC4A7-expression plasmids during ammonium prepulse
studies. Periods of exposure to 20 mM NH4Cl, Na
þ-free buffers or 30 mM DMA are marked above the traces. X-axis scale bar denotes 5 min. Groups compared by re-
peated-measures two-way ANOVA over the 280 time points between 60 and 900 s after reintroduction of Naþ-containing buffer. (B) shows the zoomed in section be-
tween time points 0 and 600 s after reintroduction of Naþ-containing buffer. Error bars denotes SEM. Groups compared by repeated-measures two-way ANOVA. (C) Net
base uptake for each group calculated at specified pHi values. Slopes compared by least-squares linear regression analyses. (D) Final plateau pHi after recovery from in-
tracellular acidosis. P<0.01, by repeated-measures one-way ANOVA; **P<0.01, by paired t-test after Bonferroni correction. (E) Representative immunoblot of samples af-
ter transfection with vector or overexpression plasmids, quantified in (F), where the cells transfected with overexpression plasmids had higher expression levels
compared to vector control, *P<0.05, by paired t-test after Bonferroni correction. There were no differences when the three overexpression studies were compared to
each other by repeated-measures one-way ANOVA.
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associated genetic variation, to gene expression, and subse-
quently to gene function that alters cellular behaviour supports
these genetic studies as a route to the discovery of drug targets.
Materials and Methods
Study samples
This study had ethical approval from Queen Mary, University of
London (Protocol No.: Plaque-WHRI-01; NRES ref: 08/H0704/140,
and subsequent amendments). Umbilical cords for cell isolation
were obtained from the Royal London Hospital which serves the
east London population where the two largest self-reported eth-
nic groups were Bangladeshi (32%) and White British (31%), with
21% of households being multi-ethnic. All tissue samples were
fully anonymous before distribution to the recipient analysis
groups, as per ethical approval. We derived primary cultures of
human umbilical artery vascular smooth muscle cells (VSMCs)
based on cell explants cultured on 0.2% w/v gelatin-coated poly-
styrene as established previously (41). We derived primary cul-
tures of human umbilical vein endothelial cells (VECs) based on
endoluminal collagenase digestion, cultured on 0.2% w/v
gelatin-coated polystyrene as established previously (42).
The A10 rat thoracic aorta vascular smooth muscle cell line
was obtained commercially from ATCC (CRL-1476) for
overexpression studies. All cells were used before a maximal
passage number of 6. Where indicated, serum-free media was
used to induce synchronised cell arrest of VSMCs (27).
Genotyping
DNA was extracted from cell culture samples (Qiagen, 69509)
and genotyped in an array using the KASPTM method (Applied
Bioscience). The primers used are listed in Supplementary
Material, Table S2. The minor allele frequency of the study
population (19.8%) approximates those in EUR (21.5%) and SAS
(18.1%) in the 1000 Genomes Project samples.
Allelic imbalance analyses
Total cellular RNA was isolated from cell culture samples
(Macherey-Nagel, 740955), and reverse transcribed (Promega,
M170). End-point RT-PCR was conducted using the primers
listed in Supplementary Material, Table S3. The PCR products
were size-separated via agarose gel electrophoresis, excised and
cleaned up (Promega, A9281) before Sanger sequencing was
conducted by the commercial service at the Genome Centre,
Queen Mary University of London. The PeakPicker software
(McGill University and Ge´nome Que´bec Innovation Centre,
Figure 8. Naþ/HCO3 co-transport and Na
þ/Hþexchange activities are similar in VSMCs, but Naþ/Hþexchange dominates in VECs. Average net base uptake plotted
against average pHi for each corresponding time-point after NH
þ
4 -prepulse-induced intracellular acidosis of (A) VSMCs (n¼12) and (B) VECs (n¼20) in the presence and
absence of either 30 mM DMA or CO2/HCO

3 . Open circles denote studies with CO2/HCO

3 ; cross, CO2/HCO

3 þ DMA; plus, CO2/HCO3 -free conditions. (C) shows result of
end-point RT-PCR (10 ng of reverse-transcribed RNA) of selected pHi regulators (long and short variants of SLC4A7, together with other pHi regulators SLC4A4 (NBCe1)
and SLC9A1 (NHE1)) in paired samples of VSMCs and VECs, showing significant inter-sample variability. b-actin included as positive control.
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California) was used to determine relative allele ratios from het-
erozygotes of interest (43).
Formaldehyde-assisted isolation of regulatory elements
Formaldehyde-assisted isolation of regulatory elements (FAIRE)
was conducted as adapted from the commercial kit from
Millipore (#16-201). Briefly, formaldehyde was added to allow
protein-DNA cross-linking, with glycine further added to
quench the residual formaldehyde. The cells were lysed and the
DNA sheared by a probe sonicator (Jencons Scientific, 690-024)
for three pulses of 10 s, producing sheared DNA of lengths be-
tween 200 and 800 base pairs. The samples were de-crosslinked
by heating, and the residual proteins were digested by protein-
ase K. The DNA fragments were then suitable for isolation by
DNA extraction columns (Promega, A9281). The isolated
chromatin-associated DNA was used for allelic imbalance anal-
yses as described above.
Electrophoretic mobility assay (EMSA) and DNA
pulldown
Commercial complementary single-stranded oligonucleotides
(either unlabelled or biotin-labelled) were annealed to form
double-stranded oligonucleotides (see Supplementary Material,
Table S4 for sequences). Nuclear extracts were isolated from
VSMCs and VECs (Millipore, #2900). Both the nuclear extracts
and double-stranded oligonucleotides were used for both
EMSAs and DNA pulldown assays.
For EMSAs, the reaction mixture was combined with study-
specific quantities of nuclear proteins, labelled antibody and
unlabelled competitor antibodies. Unless where specified, quanti-
ties of nuclear proteins were 10 mg (2 mg/ml) and labelled oligonu-
cleotides were 10 femtomoles (1014 moles). When required for
supershift assays, 1 or 5 ng of the antibody (rabbit anti-AP2c IgG
antibody, Santa Cruz, sc-8977 X; goat anti-PHOX2A IgG antibody,
Santa Cruz, sc-13229 X; or rabbit anti-ZAC1 IgG antibody, Santa
Cruz, sc-22811 X) was pre-incubated with the nuclear proteins be-
fore adding to the reactions. To account for the variable volumes
of reactants, the final reaction volume was made up to 20 ml with
nuclease-free water. The reaction mixture was electrophoresed
on a 4% non-denaturing acrylamide gel, electrotransferred onto a
nylon membrane (Amersham, RPN119B) and crosslinked with
oven drying followed by 254 nm ultraviolet light at a dose of 0.12
J/cm2 (Biolink, BLX-254E). The biotin-labelled double-stranded oli-
gonucleotides were detected by the LightShiftVR
Chemiluminescent EMSA Kit (ThermoScientific, #89880).
DNA pulldown assays were conducted using streptavidin-
conjugated agarose beads mixture (Sigma, S1638) based on
manufacturer’s protocol as summarised below. For every reac-
tion, 1 nmol of biotin-labelled double-stranded oligonucleotides
were immobilised onto 50 ml of streptavidin-conjugated agarose
beads mixture and washed. The bead-oligonucleotide complex
was incubated with 500 mg of nuclear extract, and subsequently,
the bead-oligonucleotide-protein complex was washed. The
pulled-down proteins were eluted with 100 ml of 2x Laemmli
buffer at 70

C. The eluate underwent SDS-PAGE gel electropho-
resis and Ponceau S staining.
Immunoblotting and subcellular fractionation
For immunoblotting, total cellular protein was isolated using
RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.5% w/v sodium
deoxycholate, 1% v/v NP-40, 0.1% w/v sodium dodecylsulfate)
supplemented with protease inhibitors.
For subcellular fractionation by differential centrifugation,
cells were homogenized with a homogenization buffer (10 mM
Tris HCl pH 7.2, 1 mM EDTA pH 8.0, 250 mM sucrose) supple-
mented with protease inhibitor mixture. The cell homogenates
were subjected to differential centrifugation with the superna-
tant removed at each step and resuspension in RIPA supple-
mented with protease inhibitors. The centrifugation sequences
were: 900 g for 10 min (nuclear and cell debris fraction), 10,000 g
for 5 min (mitochondrial/lysosomes/peroxisomes fraction) and
100,000 g for 60 min (membrane fraction). Each separate pellet
was resuspended in RIPA buffer. The final supernatant was kept
as the cytoplasmic fraction.
The samples derived from either method were electrophor-
esed using SDS-PAGE gels, electrotransferred to a PVDF
membrane (Amersham, 10600021) and detected by enhanced
chemiluminescence (Amersham, RPN2232). The antibodies
used are listed in Supplementary Material, Table S5.
Protease inhibitors reached the final concentration of 1 mM phe-
nylmethanesulfonyl fluoride (Sigma, P7626), 2 mM leupeptin
hemisulfate (Sigma, L2884), 1.5 mM pepstatin A (Sigma, P2465)
and 0.15 mM aprotinin (Sigma, A1153) after addition to the
samples.
Intracellular pH (pHi) and Na
þ/HCO3 -dependent pHi
recovery from intracellular acidosis
Experiments were conducted with cells cultured on 0.1% w/v
poly-lysine (Sigma, P8920)-coated polystyrene flasks (BD-Falcon,
#353107). Studies were conducted in a temperature-controlled
stand and ambient air warmed to 37

C for 30 min before initiation
of experiments. Ports were created to allow for aspiration or bub-
bling of gasses (5% CO2/95% air or 100% air) at a constant rate.
Cells were incubated with 1 mM BCECF-AM (ThermoFisher, B-
1170) for 20 min before being rinsed. A baseline F495/F440 ratio was
observed for 5 min before paired digital images at excitation
wavelengths of 495 nm and 440 nm were obtained with exposure
times of 800 and 1000 milliseconds respectively (Visitron
Systems, Visiview Version 3), obtained every 3 s at periods of in-
terest, otherwise at 15-s intervals. The initial resting baseline and
final plateau was recorded for 1 min. A calibration curve was ob-
tained at the end of the study where the cells are exposed to
high-potassium buffers of varying pH with 5 mg/L nigericin
(Sigma, N7143). These curves were highly reproducible, with coef-
ficients of variation of<5%, and were near-linear in the pHi sec-
tion of interest (Supplementary Material, Fig. S10). For the
constituents of buffers, see Supplementary Material, Table S6.
The buffering capacity (mmol/L) was calculated based on the re-
sponse to wash-out of NH4Cl using the formula b¼D[NHþ4 ]i/DpHi.
The [NHþ4 ]i was calculated from the Henderson-Hasselbalch
equation assuming equilibration of NH3 across the membrane
and using a pKa of 9.2, and DpHi calculated by the difference in
pHi before and after washout of NH4Cl (18) The rate of net base
uptake (mmol/L/min) during recovery from intracellular acidosis
was calculated as the product of the rate of pH gain (DpHi per
minute calculated by linear regression over 15 s) and the buffering
capacity (18).
Cloning
The coding sequence of SLC4A7 (Homo sapiens solute carrier
family 4 member 7, transcript variant 1, mRNA Sequence ID:
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refjNM_003615.4) was subcloned to pcDNA3.1(þ) vector. Site-
directed in vitro mutagenesis was conducted using the
QuikChange II Site-Directed Mutagenesis Kit (Agilent, #200523),
using the primer pair, forward: CCTGACGCTGACTCTCTTGG
GAACTTCTGGAGG; reverse: CCTCCAGAAGTTCCCAAGAGAGT
CAGCGTCAGG. PCR-driven overlap extension to generate the
splice variant lacking Cassette II (Homo sapiens solute carrier
family 4 member 7, transcript variant 3, mRNA Sequence ID:
refjNM_001258380.1) was based on the protocol described by
Heckman and Pease (44), using the primer pair, forward:
CTTGAAAGGAATGGTATTTTGGCCTCT; reverse: AGAGGCCAAA
ATACCATTCCTTTCAAG. All plasmids had their sequences con-
firmed by Sanger sequencing.
Cell culture and transfection
Transfections for A10 cells were conducted using liposome-
based transfection with the X-tremeGENE reagent (Roche,
06366244001). For 10 cm2 surface area, ratios of 1 mg of plasmid,
200 ml of DMEM (Sigma, M4530) and 3 ml of the X-tremeGENE re-
agent were allowed to incubate for 20 min at room temperature
before being added drop-wise into the culture surface al-
ready containing 2 ml of fresh media. The cells were then incu-
bated in a humidified incubator kept at 37

C and 5% CO2 for 48 h
without the need to replace the culture media prior to
experiments.
Statistical analyses
Comparisons between two independent groups were conducted
using unpaired, two-tailed Student’s t-test or the Mann-
Whitney U-test for parametric and non-parametric distribu-
tions, respectively. Comparisons between two paired groups
were conducted using two-tailed, one-sample t-test or the
Wilcoxon sign-ranked for parametric and non-parametric dis-
tributions, respectively. Predicted linear relationships were ana-
lyzed by least-squares linear regression and the derived
slopes and y-axis intercepts compared. Comparisons between
multiple paired groups were conducted using repeated-
measures analysis of variance (ANOVA). Examination of the in-
fluence of two different independent variables (e.g. genotype
and dose) on one dependent variable was conducted using two-
way ANOVA. Graphical presentation and statistical analyses
were conducted using Prism v5 (GraphPad Software). Values
were expressed as mean6 standard error of the mean. A
p-value of less than 0.05 was considered statistically significant.
Multiple testing was further adjusted for by Bonferroni
correction.
Supplementary Material
Supplementary Material is available at HMG online.
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